New User? Sign Up | Sign In

Insider Trading - PhaseBio Pharmaceuticals Inc (PHAS)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
PHAS Insider Trading Transactions for PhaseBio Pharmaceuticals Inc
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-07-01
Sale
2019-07-03
4:28 pm
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
2,908 $14 $40,712 1,818,638
(Indirect)
View
2019-06-18
Sale
2019-06-20
7:09 pm
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
400 $14 $5,600 1,820,656
(Indirect)
View
2018-12-13
Purchase
2018-12-17
4:24 pm
PhaseBio Pharmaceuticals Inc PHAS Ballance David James
VP
1,000 $3.94 $3,940 7,600
(Direct)
View
2018-12-17
Purchase
2018-12-17
4:19 pm
PhaseBio Pharmaceuticals Inc PHAS Hutson Nancy J
Director
1,000 $4.46 $4,460 1,000
(Indirect)
View
2018-12-13
Purchase
2018-12-17
4:18 pm
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
1,000 $3.69 $3,690 51,199
(Indirect)
View
2018-12-07
Purchase(A)
2018-12-13
5:04 pm
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
1,500 $3.869 $5,803 50,199
(Indirect)
View
2018-12-11
Purchase
2018-12-11
4:18 pm
PhaseBio Pharmaceuticals Inc PHAS York Michael
VP
1,500 $3.88 $5,820 1,500
(Direct)
View
2018-12-07
Purchase
2018-12-11
4:16 pm
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
5,000 $3.84 $19,200 5,000
(Direct)
View
2018-12-07
Purchase
2018-12-11
4:12 pm
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
3,000 $3.872 $11,616 51,699
(Indirect)
View
2018-12-04
Purchase
2018-12-06
09:15 am
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
4,000 $3.13 $12,520 1,820,933
(Indirect
Direct)
View
2018-10-22
Purchase
2018-10-24
5:01 pm
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
1,800,000 $5 $9,000,000 6,641,634
(Indirect)
View
2018-10-22
Purchase
2018-10-24
4:20 pm
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
20,000 $5 $100,000 590,168
(Indirect)
View
2018-10-22
Purchase
2018-10-24
4:19 pm
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
300,000 $5 $1,500,000 1,820,933
(Direct
Indirect)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-10-07
Option Award
2019-10-07
7:11 pm
N/A
2029-10-07
PhaseBio Pharmaceuticals Inc PHAS Hanson Kristopher
VP
66,000 $4.17 66,000
(Direct)
View
2019-09-06
Exercise
2019-09-10
4:10 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,000 $1.24 158,767
(Direct)
View
2019-09-06
Exercise
2019-09-10
4:10 pm
2018-10-08
2024-11-04
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,000 $1.24 158,767
(Direct)
View
2019-08-21
Exercise
2019-08-22
7:42 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
10,000 $1.69 110,582
(Direct)
View
2019-08-21
Exercise
2019-08-22
7:42 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
5,000 $1.44 110,582
(Direct)
View
2019-08-21
Exercise
2019-08-22
7:42 pm
N/A
2026-05-12
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
10,000 $1.69 110,582
(Direct)
View
2019-08-21
Exercise
2019-08-22
7:42 pm
N/A
2027-04-21
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
5,000 $1.44 110,582
(Direct)
View
2019-05-22
Exercise
2019-05-24
2:22 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
15,000 $1.69 120,582
(Direct)
View
2019-05-22
Exercise
2019-05-24
2:22 pm
N/A
2026-05-12
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
15,000 $1.69 120,582
(Direct)
View
2019-05-17
Exercise
2019-05-21
6:27 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,913 $2.27 90,243
(Direct)
View
2019-05-17
Exercise
2019-05-21
6:27 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,131 $1.24 90,243
(Direct)
View
2019-05-17
Exercise
2019-05-21
6:27 pm
2016-12-03
2022-12-21
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,913 $2.27 90,243
(Direct)
View
2019-05-17
Exercise
2019-05-21
6:27 pm
2018-03-14
2024-03-31
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,131 $1.24 90,243
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:44 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Mukhopadhyay Bibhash
Director
11,000 $13.23 11,000
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:39 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Klein Peter Justin
Director
11,000 $13.23 11,000
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:38 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS van den Broek Richard
Director
2,750 $13.23 2,750
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:37 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS HARRIGAN EDMUND
Director
4,583 $13.23 4,583
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:36 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Loewy Caroline M
Director
9,167 $13.23 9,167
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:36 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Hutson Nancy J
Director
11,000 $13.23 11,000
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:35 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
11,000 $13.23 11,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:23 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
36,000 $3.15 36,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:07 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS York Michael
VP
45,000 $3.15 45,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:03 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS van den Broek Richard
Director
22,000 $3.15 23,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:03 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS van den Broek Richard
Director
23,000 $3.15 23,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:02 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
36,000 $3.15 36,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:00 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
100,000 $3.15 100,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:55 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Loewy Caroline M
Director
8,900 $3.15 8,900
(Direct)
View
2019-03-01
Option Award
2019-03-01
4:52 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Lee John Sang
Chief Medical Officer
100,000 $3.15 100,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:48 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Klein Peter Justin
Director
36,000 $3.15 36,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:47 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Hutson Nancy J
Director
8,900 $3.15 8,900
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:44 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Ballance David James
VP
45,000 $3.15 45,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:42 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Arnold Susan Elizabeth
VP
45,000 $3.15 45,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:39 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
263,000 $3.15 263,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:38 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Mukhopadhyay Bibhash
Director
36,000 $3.15 36,000
(Direct)
View
2018-12-13
Option Award
2018-12-17
4:26 pm
N/A
2028-12-13
PhaseBio Pharmaceuticals Inc PHAS HARRIGAN EDMUND
Director
68,966 $3.65 68,966
(Direct)
View
2018-10-22
Conversion
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Klein Peter Justin
Director
2,303 $0 2,306
(Direct)
View
2018-10-22
Exercise
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Klein Peter Justin
Director
103 $0.12 2,306
(Direct)
View
2018-10-22
Exercise
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Klein Peter Justin
Director
103 $0.12 2,306
(Direct)
View
2018-10-22
Sale
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Klein Peter Justin
Director
3 $5 2,306
(Direct)
View
2018-10-22
Conversion
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Klein Peter Justin
Director
2,303 $0 2,306
(Direct)
View
2018-10-22
Conversion
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
4,841,634 $0 6,641,634
(Indirect)
View
2018-10-22
Exercise
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
49,030 $0.12 6,641,634
(Indirect)
View
2018-10-22
Exercise
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
49,030 $0.12 6,641,634
(Indirect)
View
2018-10-22
Sale
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
1,177 $5 6,641,634
(Indirect)
View
2018-10-22
Conversion
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
3,279,627 $0 6,641,634
(Indirect)
View
2018-10-22
Exercise
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
181,190 $0.12 6,641,634
(Indirect)
View
2018-10-22
Exercise
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
181,190 $0.12 6,641,634
(Indirect)
View
2018-10-22
Sale
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
4,349 $5 6,641,634
(Indirect)
View
2018-10-22
Conversion
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
437,706 $0 6,641,634
(Indirect)
View
2018-10-22
Conversion
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
1,124,301 $0 6,641,634
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
577,486 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
58,152 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
275,055 $0 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
7,053 $0.12 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
7,053 $0.12 590,168
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
170 $5 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
710 $0.12 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
710 $0.12 590,168
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
18 $5 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
3,359 $0.12 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
3,359 $0.12 590,168
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
81 $5 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
9,847 $0.12 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
9,847 $0.12 590,168
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
237 $5 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
991 $0.12 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
991 $0.12 590,168
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
24 $5 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
4,690 $0.12 590,168
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
4,690 $0.12 590,168
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
113 $5 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
119,408 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
12,025 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
56,874 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
347,250 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
34,968 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
165,395 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
47,140 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
4,746 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
22,452 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
63,688 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
6,413 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:20 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
30,334 $0 590,168
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
52,690 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
1,683,420 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
150,612 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
4,846 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
266,481 $0 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
19,061 $0.12 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
19,061 $0.12 1,820,933
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
458 $5 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
1,731 $0.12 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
1,731 $0.12 1,820,933
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
42 $5 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
47,458 $0.12 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
47,458 $0.12 1,820,933
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
1,139 $5 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
4,309 $0.12 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
4,309 $0.12 1,820,933
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
104 $5 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
41,414 $0.12 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
41,414 $0.12 1,820,933
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
994 $5 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
52,690 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
42,530 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
3,862 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
4,846 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
174,699 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
13,609 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
1,044,764 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
94,874 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
149,320 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
13,558 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
40,420 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
272,107 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
24,709 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
226,061 $0 1,820,933
(Indirect)
View
Goto page 0, 1, Next